TY - JOUR A1 - Borck, Guntram A1 - Hög, Friederike A1 - Dentici, Maria Lisa A1 - Tan, Perciliz L. A1 - Sowada, Nadine A1 - Medeira, Ana A1 - Gueneau, Lucie A1 - Thiele, Holger A1 - Kousi, Maria A1 - Lepri, Francesca A1 - Wenzeck, Larissa A1 - Blumenthal, Ian A1 - Radicioni, Antonio A1 - Schwarzenberg, Tito Livio A1 - Mandriani, Barbara A1 - Fischetto, Rita A1 - Morris-Rosendahl, Deborah J. A1 - Altmüller, Janine A1 - Reymond, Alexandre A1 - Nürnberg, Peter A1 - Merla, Giuseppe A1 - Dallapiccola, Bruno A1 - Katsanis, Nicholas A1 - Cramer, Patrick A1 - Kubisch, Christian T1 - BRF1 mutations alter RNA polymerase III–dependent transcription and cause neurodevelopmental anomalies Y1 - 2015/02/01 JF - Genome Research JO - Genome Research SP - 155 EP - 166 DO - 10.1101/gr.176925.114 VL - 25 IS - 2 UR - http://genome.cshlp.org/content/25/2/155.abstract N2 - RNA polymerase III (Pol III) synthesizes tRNAs and other small noncoding RNAs to regulate protein synthesis. Dysregulation of Pol III transcription has been linked to cancer, and germline mutations in genes encoding Pol III subunits or tRNA processing factors cause neurogenetic disorders in humans, such as hypomyelinating leukodystrophies and pontocerebellar hypoplasia. Here we describe an autosomal recessive disorder characterized by cerebellar hypoplasia and intellectual disability, as well as facial dysmorphic features, short stature, microcephaly, and dental anomalies. Whole-exome sequencing revealed biallelic missense alterations of BRF1 in three families. In support of the pathogenic potential of the discovered alleles, suppression or CRISPR-mediated deletion of brf1 in zebrafish embryos recapitulated key neurodevelopmental phenotypes; in vivo complementation showed all four candidate mutations to be pathogenic in an apparent isoform-specific context. BRF1 associates with BDP1 and TBP to form the transcription factor IIIB (TFIIIB), which recruits Pol III to target genes. We show that disease-causing mutations reduce Brf1 occupancy at tRNA target genes in Saccharomyces cerevisiae and impair cell growth. Moreover, BRF1 mutations reduce Pol III–related transcription activity in vitro. Taken together, our data show that BRF1 mutations that reduce protein activity cause neurodevelopmental anomalies, suggesting that BRF1-mediated Pol III transcription is required for normal cerebellar and cognitive development. ER -